Davenport & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
FFM
PCM
OIAM
GI
BIAS
IP
Davenport & Co's DXCM Position: Q2 2026 in Review
Davenport & Co reduced its DexCom (DXCM) stake by 13% in Q2 2026, selling an estimated $251K and leaving 24,951 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #614.
Davenport & Co first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.11M in Q2 2025. 151 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Davenport & Co held 24,951 shares of DexCom worth $1.68M as of Q2 2026.
- Davenport & Co sold 3,769 DexCom shares in Q2 2026, an estimated $251K.
- DexCom made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #614 holding.
- Davenport & Co first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
- Davenport & Co's DexCom position peaked at $6.11M in Q2 2025.
- 151 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.